Drug Trial Radar · NCT05109091
Study of ATH434 in Participants with Multiple System Atrophy
Last checked: Nov 19, 2026Latest source record: Dec 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
Jul 1, 2022
Primary completion
Nov 28, 2024
Study completion Nov 28, 2024
Sponsor
- Lead sponsor
- Alterity TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy
Conditions
- Multiple System Atrophy
Interventions
ATH434 dose level 1Drug
ATH434 taken BID
ATH434 dose level 2Drug
ATH434 taken BID
PlaceboDrug
Placebo taken BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in iron content as measured by brain MRITime frame: Change from Baseline to Week 52
Locations
23 sites in 6 countries. Site status is shown where the registry gives one.
University of California San Diego
La Jolla, California
Rush University Medical Center
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
Columbia University Irving Medical Center
New York, New York
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma
Vanderbilt University Medical Center
Nashville, Tennessee
St Vincent's Hospital (Sydney)
Darlinghurst, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
CHU de Bordeaux/Groupe Hospitalier Pellegrin
Bordeaux, France
CHU de Marseille/Hôpital de la Timone
Marseille, France
CHU de Toulouse/Hôpital Pierre-Paul Riquet
Toulouse, Haute-Garonne, France
CHU/HU Pitié Salpêtrière
Paris, Île-de-France Region, France
Policlinico di Milano
Milan, Italy
Azienda Ospedaliero-Universitaria Pisana
Pisa, Italy
AOU San Giovanni di Dio Ruggi d'Aragona
Salerno, Italy
IRCCS Istituto Delle Scienze Neurologiche di Bologna
Bologna, Bologna, Italy
New Zealand Brain Research Institute
Christchurch, New Zealand
Auckland City Hospital
Grafton, New Zealand
University College London
London, England, United Kingdom
Newcastle University
Newcastle upon Tyne, England, United Kingdom
Salford Royal Hospital
Salford, England, United Kingdom
Queen Elizabeth University Hospital
Glasgow, Scotland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.